Suppr超能文献

抗肿瘤剂。139. 硫代秋水仙碱类似物5,6-二氢-6(S)-(酰氧基)-和5,6-二氢-6(S)-[(芳酰氧基)甲基]-1,2,3-三甲氧基-9-(甲硫基)-8H-环庚[a]萘-8-酮作为新型细胞毒性和抗有丝分裂剂的合成及生物学评价。

Antitumor agents. 139. Synthesis and biological evaluation of thiocolchicine analogs 5,6-dihydro-6(S)-(acyloxy)- and 5,6-dihydro-6(S)-[(aroyloxy)methyl]-1,2,3-trimethoxy-9-(methylthio)-8H- cyclohepta[a]naphthalen-8-ones as novel cytotoxic and antimitotic agents.

作者信息

Sun L, McPhail A T, Hamel E, Lin C M, Hastie S B, Chang J J, Lee K H

机构信息

Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Chapel Hill 27599.

出版信息

J Med Chem. 1993 Mar 5;36(5):544-51. doi: 10.1021/jm00057a004.

Abstract

A series of novel thiocolchicine analogs, 5,6-dihydro-6(S)-(acyloxy)-and 5,6-dihydro-6(S)-[(aroyloxy)-methyl]-1,2,3-trimethoxy-9-(methylthi o)-8H- cyclohepta[a]naphthalen-8-ones, possessing a six-membered ring B, have been synthesized and evaluated for their cytotoxicity against various tumor cell lines, including solid tumor cell lines, and for their interaction with tubulin. The configuration of the parent alcohol (compound 5) was established unequivocally as (aR,6S) by X-ray crystallographic analysis. The side chain at the C(6) position is in a pseudoaxial orientation. The optical properties and 1H NMR data indicated that these compounds have the same conformations in solution as in the solid state. Biological results showed that compounds (5, 6, 14, 15, 17, and 18) bearing a small side chain at C(6) demonstrate high potency in inhibiting tubulin polymerization and binding of radiolabeled colchicine to tubulin. The most cytotoxic compounds were 14, 15, 17, and 18, with good activity against several solid tumor cell lines. To explain the strong antitubulin activity of compound 5 (with an aR configured biaryl system in contrast to the aS configuration previously described for colchicinoids, allocolchicinoids, and steganacin) we speculate that a rapid atropisomerism equilibrium must exist for 5 and its active derivatives. This equilibrium would yield adequate amounts of aS-configured conformers that interact, strongly with tubulin. Since the optically inactive 18 is also a potent inhibitor of tubulin, the configuration of the side chain of these six-membered ring B analogs cannot be essential for their binding to tubulin. Instead we propose that the size of ring B and of its side chain play important roles in tubulin binding activity by affecting the rotation of the rings A and C along their linking C-C bond axis.

摘要

一系列新型硫代秋水仙碱类似物,即5,6-二氢-6(S)-(酰氧基)-和5,6-二氢-6(S)-[(芳酰氧基)甲基]-1,2,3-三甲氧基-9-(甲硫基)-8H-环庚[a]萘-8-酮,具有六元环B,已被合成并评估其对包括实体瘤细胞系在内的各种肿瘤细胞系的细胞毒性以及它们与微管蛋白的相互作用。通过X射线晶体学分析明确确定母体醇(化合物5)的构型为(aR,6S)。C(6)位的侧链处于假轴向取向。光学性质和1H NMR数据表明这些化合物在溶液中的构象与固态时相同。生物学结果表明,在C(6)位带有小侧链的化合物(5、6、14、15、17和18)在抑制微管蛋白聚合以及放射性标记秋水仙碱与微管蛋白结合方面表现出高效力。细胞毒性最强的化合物是14、15、17和18,对几种实体瘤细胞系具有良好活性。为了解释化合物5(与之前描述的秋水仙碱类、别秋水仙碱类和隐丹参酮的aS构型相反,具有aR构型的联芳基系统)的强抗微管蛋白活性,我们推测5及其活性衍生物必定存在快速的阻转异构平衡。这种平衡会产生足够量的aS构型构象体,它们与微管蛋白强烈相互作用。由于光学无活性的18也是微管蛋白的有效抑制剂,这些六元环B类似物侧链的构型对于它们与微管蛋白的结合并非必不可少。相反,我们提出环B及其侧链的大小通过影响环A和C沿其连接的C-C键轴的旋转,在微管蛋白结合活性中起重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验